Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.
biodegradable nanoparticles
clinical trials
microneedles
psoriasis
psoriasis versus atopic dermatitis
skin inflammatory diseases
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
07 May 2021
07 May 2021
Historique:
received:
23
03
2021
revised:
30
04
2021
accepted:
06
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
17
6
2021
Statut:
epublish
Résumé
Research in the pathogenesis of inflammatory skin diseases, such as skin dermatitis and psoriasis, has experienced some relevant breakthroughs in recent years. The understanding of age-related factors, gender, and genetic predisposition of these multifactorial diseases has been instrumental for the development of new pharmacological and technological treatment approaches. In this review, we discuss the molecular mechanisms behind the pathological features of psoriasis, also addressing the currently available treatments and novel therapies that are under clinical trials. Innovative therapies developed over the last 10 years have been researched. In this area, advantages of nanotechnological approaches to provide an effective drug concentration in the disease site are highlighted, together with microneedles as innovative candidates for drug delivery systems in psoriasis and other inflammatory chronic skin diseases.
Identifiants
pubmed: 34067151
pii: ijms22094983
doi: 10.3390/ijms22094983
pmc: PMC8125586
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Portuguese Science and Technology Foundation (FCT/MCT) and from European Funds (PRODER/COMPETE) under the project reference UIDB/04469/2020 (strategic fund), co-financed by FEDER, under the Partnership Agreement PT2020
ID : UIDB/04469/2020
Références
RSC Adv. 2020 Apr 7;10(24):14040-14049
pubmed: 35498446
Br J Dermatol. 2019 Jul;181(1):88-95
pubmed: 30734266
J Am Acad Dermatol. 2003 May;48(5):760-7
pubmed: 12734506
Am J Hum Genet. 2011 Sep 9;89(3):432-7
pubmed: 21839423
N Engl J Med. 2012 Mar 29;366(13):1181-9
pubmed: 22455412
Clinicoecon Outcomes Res. 2017 Mar 06;9:181-188
pubmed: 28293115
Can Fam Physician. 2017 Apr;63(4):278-285
pubmed: 28404701
Methods Enzymol. 2009;464:105-29
pubmed: 19903552
J Sci Food Agric. 2018 Aug;98(11):4042-4049
pubmed: 29377147
JAMA Dermatol. 2016 Jul 1;152(7):807-15
pubmed: 27096709
J Biomed Nanotechnol. 2010 Oct;6(5):558-68
pubmed: 21329048
Drug Metab Dispos. 2011 Sep;39(9):1577-88
pubmed: 21677063
PLoS One. 2020 Nov 3;15(11):e0241575
pubmed: 33141869
Int J Mol Sci. 2018 Feb 09;19(2):
pubmed: 29425183
J Am Acad Dermatol. 2006 Jan;54(1):1-15; quiz 16-8
pubmed: 16384751
Indian J Dermatol Venereol Leprol. 2015 Jul-Aug;81(4):344-55
pubmed: 26144849
J Allergy Clin Immunol. 2017 Jul;140(1):109-120
pubmed: 28043870
J Dermatolog Treat. 2007;18(2):76-83
pubmed: 17520463
JBMR Plus. 2020 Nov 10;4(12):e10417
pubmed: 33354643
Expert Opin Drug Saf. 2009 Nov;8(6):769-79
pubmed: 19998529
Dermatol Clin. 2015 Jan;33(1):111-25
pubmed: 25412787
Front Pharmacol. 2015 Sep 30;6:219
pubmed: 26483690
J Exp Med. 2011 Oct 24;208(11):2321-33
pubmed: 22006976
Photochem Photobiol Sci. 2017 Mar 16;16(3):283-290
pubmed: 27892584
Clin Ther. 2017 May;39(5):930-945
pubmed: 28457494
J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1616-1626
pubmed: 28653490
J Drug Target. 2013 May;21(5):497-506
pubmed: 23594093
J Invest Dermatol. 2012 Jan;132(1):135-43
pubmed: 21850017
Psoriasis (Auckl). 2018 Jan 04;8:1-5
pubmed: 29441315
Am J Clin Dermatol. 2011 Apr 1;12(2):143-6
pubmed: 21184623
Br J Dermatol. 2018 Jan;178(1):e24-e25
pubmed: 28667745
Eur J Pharm Biopharm. 2012 Sep;82(1):49-57
pubmed: 22705640
J Autoimmun. 2015 Nov;64:66-73
pubmed: 26215033
J Microencapsul. 2008 Mar;25(2):111-20
pubmed: 18246489
Int J Pharm. 2011 Sep 20;416(2):478-85
pubmed: 21419203
Clin Dermatol. 2008 Jul-Aug;26(4):380-6
pubmed: 18691519
J Dermatolog Treat. 2017 Feb;28(1):18-20
pubmed: 27771982
Acta Dermatovenerol Croat. 2003;11(2):80-7
pubmed: 12773264
Drug Deliv Transl Res. 2017 Feb;7(1):37-52
pubmed: 27981502
Adv Drug Deliv Rev. 2013 Oct;65(10):1316-30
pubmed: 23415951
Dermatol Ther (Heidelb). 2017 Sep;7(3):281-292
pubmed: 28639011
Br J Clin Pharmacol. 2017 May;83(5):991-1001
pubmed: 27859546
Acta Biochim Pol. 2014;61(4):679-86
pubmed: 25566549
Br J Dermatol. 2002 Mar;146(3):414-22
pubmed: 11952541
Ann Rheum Dis. 2009 Jun;68(6):805-11
pubmed: 19015206
Int J Pharm. 2009 Jun 22;375(1-2):148-54
pubmed: 19481700
Immunity. 2015 Oct 20;43(4):727-38
pubmed: 26431948
N Engl J Med. 2012 Jul 19;367(3):274; author reply 275
pubmed: 22808966
Psoriasis (Auckl). 2016 Jul 28;6:105-111
pubmed: 29387597
Dermatol Ther. 2020 Jan;33(1):e13185
pubmed: 31830367
Drug Des Devel Ther. 2013 Apr 15;7:339-48
pubmed: 23620660
J Control Release. 2016 Dec 10;243:132-145
pubmed: 27725194
Acta Biochim Pol. 2016;63(1):17-29
pubmed: 26824295
Clin Exp Dermatol. 2018 Jul;43(5):529-535
pubmed: 29341195
J Am Acad Dermatol. 2016 Oct;75(4):736-739
pubmed: 27473452
Int J Mol Sci. 2019 Feb 10;20(3):
pubmed: 30744173
N Engl J Med. 2016 Jul 28;375(4):345-56
pubmed: 27299809
Nat Rev Immunol. 2009 Aug;9(8):556-67
pubmed: 19575028
Expert Opin Drug Deliv. 2014 Dec;11(12):1833-47
pubmed: 25078031
Adv Drug Deliv Rev. 2007 Jul 10;59(6):478-90
pubmed: 17543416
Curr Opin Immunol. 2017 Dec;49:1-8
pubmed: 28738209
Clin Exp Dermatol. 2019 Jul;44(5):498-505
pubmed: 30474246
J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1435-44
pubmed: 19614856
Chem Phys Lipids. 2015 Feb;186:9-16
pubmed: 25447290
N Engl J Med. 2011 Aug 18;365(7):620-8
pubmed: 21848462
Mol Pharm. 2014 Sep 2;11(9):2989-3001
pubmed: 25057896
Lancet. 2008 May 17;371(9625):1665-74
pubmed: 18486739
J Allergy Clin Immunol. 2014 Apr;133(4):1032-40
pubmed: 24679469
Int J Paleopathol. 2018 Dec;23:96-99
pubmed: 30573171
Artif Cells Nanomed Biotechnol. 2015 Feb;43(1):33-9
pubmed: 24040836
Br J Dermatol. 2014 Feb;170(2):274-303
pubmed: 24131260
Drug Metab Dispos. 2018 May;46(5):581-591
pubmed: 29467214
Postepy Dermatol Alergol. 2020 Apr;37(2):135-153
pubmed: 32489346
JAMA. 2020 May 19;323(19):1945-1960
pubmed: 32427307
Eur J Pharm Sci. 2017 Jan 15;97:113-134
pubmed: 27864064
Lancet. 2018 Aug 25;392(10148):650-661
pubmed: 30097359
Drug Deliv. 2010 May;17(4):187-207
pubmed: 20297904
Acta Pharmacol Sin. 2015 Jan;36(1):71-87
pubmed: 25500868
Clin Drug Investig. 2018 Feb;38(2):101-112
pubmed: 29094282
J Dermatol. 2016 May;43(5):507-14
pubmed: 26971536
Drugs. 2017 Mar;77(4):459-472
pubmed: 28213862
Clin Exp Immunol. 2004 Oct;138(1):83-93
pubmed: 15373909
An Bras Dermatol. 2018 Jan-Feb;93(1):63-66
pubmed: 29641699
Skin Pharmacol Physiol. 2018;31(2):74-86
pubmed: 29306952
J Control Release. 2015 Feb 10;199:190-7
pubmed: 25481447
Colloids Surf B Biointerfaces. 2010 Feb 1;75(2):538-42
pubmed: 19879736
Clin Dermatol. 2016 Sep-Oct;34(5):548-55
pubmed: 27638432
J Control Release. 2014 Dec 28;196:9-18
pubmed: 25278258
Int J Pharm. 2018 Oct 25;550(1-2):240-250
pubmed: 30165098
Semin Cutan Med Surg. 2016 Mar;35(2 Suppl 2):S36-44; quiz S45
pubmed: 27074696
Arch Dermatol Res. 2017 Sep;309(7):499-517
pubmed: 28674914
Int J Pharm. 2010 Jan 29;385(1-2):113-42
pubmed: 19825408
J Am Assoc Nurse Pract. 2017 Mar;29(3):157-178
pubmed: 28233460
Prog Lipid Res. 2017 Oct;68:1-11
pubmed: 28778472
J Immunol. 2006 Jun 1;176(11):7104-11
pubmed: 16709873
J Control Release. 2011 Jan 20;149(2):159-67
pubmed: 20950659
J Dermatol. 2010 Oct;37(10):894-9
pubmed: 20860740
Int J Nanomedicine. 2014 Jan 23;9:669-78
pubmed: 24489470
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1792-1799
pubmed: 28585342
Drug Dev Ind Pharm. 2010 Aug;36(8):962-71
pubmed: 20590450
Ther Clin Risk Manag. 2008 Apr;4(2):345-51
pubmed: 18728850
Int J Nanomedicine. 2010 Mar 09;5:117-28
pubmed: 20309398
Arch Dermatol Res. 2011 Jan;303(1):1-10
pubmed: 20857129
Br J Dermatol. 2015 Oct;173(4):930-9
pubmed: 26042589
Biomed Pharmacother. 2018 Nov;107:447-463
pubmed: 30103117
J Am Acad Dermatol. 1998 Oct;39(4 Pt 2):S129-33
pubmed: 9777790
Drug Deliv. 2016 May;23(4):1204-13
pubmed: 26592918
Int J Pharm. 2008 Mar 20;352(1-2):1-4
pubmed: 18249513
J Allergy Clin Immunol. 2011 Mar;127(3):787-94.e1-9
pubmed: 21377044
Rev Endocr Metab Disord. 2017 Jun;18(2):195-205
pubmed: 28176237
Front Immunol. 2019 Mar 26;10:577
pubmed: 30972071
J Am Acad Dermatol. 2012 Aug;67(2):279-88
pubmed: 22609220
N Engl J Med. 2003 Nov 20;349(21):2014-22
pubmed: 14627786
Ir J Med Sci. 2017 Feb;186(1):161-177
pubmed: 27271164
Int J Dermatol. 1999 Jan;38(1):16-24
pubmed: 10065604
Clin Immunol. 2016 Nov;172:61-64
pubmed: 27455859
J Liposome Res. 2011 Jun;21(2):134-40
pubmed: 20557280
Antioxidants (Basel). 2019 Aug 03;8(8):
pubmed: 31382599
FASEB J. 2005 Jun;19(8):1012-4
pubmed: 15802490
J Dermatol. 2012 Mar;39(3):225-30
pubmed: 22352846
Eur J Pharm Sci. 2020 Sep 1;152:105469
pubmed: 32679177
Pharm Dev Technol. 2016 Aug;21(5):554-62
pubmed: 26024238
J Clin Invest. 1995 Nov;96(5):2106-12
pubmed: 7593594
Eur J Pharm Biopharm. 2016 Nov;108:235-252
pubmed: 27519829
J Invest Dermatol. 2006 Jun;126(6):1396-402
pubmed: 16614726
Dermatol Ther. 2019 Nov;32(6):e13113
pubmed: 31600849
Toxics. 2019 Sep 22;7(4):
pubmed: 31546707
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:28-39
pubmed: 24176765
N Engl J Med. 2014 Jul 24;371(4):326-38
pubmed: 25007392
J Clin Aesthet Dermatol. 2019 Dec;12(12):28-34
pubmed: 32038762
Indian Dermatol Online J. 2017 Jul-Aug;8(4):235-245
pubmed: 28761838
Bioorg Med Chem Lett. 2016 Sep 15;26(18):4387-4393
pubmed: 27542308
Microbiol Immunol. 2018 Jan;62(1):1-13
pubmed: 29205464
Biomaterials. 2001 Nov;22(22):2959-66
pubmed: 11575470
J Cutan Med Surg. 2014 Jan-Feb;18(1):8-14
pubmed: 24377467
Exp Dermatol. 2020 Dec;29(12):1186-1190
pubmed: 32997398
Int J Mol Sci. 2019 Mar 23;20(6):
pubmed: 30909615
Cell Biochem Funct. 2019 Aug;37(6):408-423
pubmed: 31328813
Int J Pharm. 2014 Oct 1;473(1-2):591-8
pubmed: 25102113
Medicine (Baltimore). 2018 Jun;97(25):e11185
pubmed: 29924036
Clin Cosmet Investig Dermatol. 2019 Dec 31;12:953-959
pubmed: 32099435